Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

NWBO Northwest Biotherapeutics Inc (QB)

0.00278 (0.61%)
Last Updated: 12:42:34
Delayed by 15 minutes


Draw Mode:

Volume 863,740
Bid Price 0.4601
Ask Price 0.4649
News -
Day High 0.4788


52 Week Range


Day Low 0.455
Company Name Stock Ticker Symbol Market Type
Northwest Biotherapeutics Inc (QB) NWBO OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00278 0.61% 0.46178 12:42:34
Open Price Low Price High Price Close Price Prev Close
0.46 0.455 0.4788 0.459
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
198 863,740 $ 0.468714 $ 404,847 - 0.4001 - 1.11
Last Trade Time Type Quantity Stock Price Currency
12:42:34 2,350 $ 0.46178 USD

Northwest Biotherapeutics Inc (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
202.29M 1.10B 972.39M 1.93M -64.37M -0.05 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Northwest Biotherapeutics (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No NWBO Message Board. Create One! See More Posts on NWBO Message Board See More Message Board Posts

Historical NWBO Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.4910.520.4550.48016061,698,973-0.02922-5.95%
1 Month0.4990.540.43760.47422881,606,808-0.03722-7.46%
3 Months0.54360.64890.43760.5122351,623,005-0.08182-15.05%
6 Months0.840.8980.43760.5883321,670,758-0.37822-45.03%
1 Year0.6051.110.40010.65323141,868,828-0.14322-23.67%
3 Years1.642.050.38620.82779212,073,524-1.18-71.84%
5 Years0.33782.540.0050.85052822,304,0120.1239836.70%

Northwest Biotherapeutics (QB) Description

Northwest Biotherapeutics, Inc. is a development stage biotechnology company focused on discovering, developing and commercializing immunotherapy products that generate and enhance immune system responses to treat cancer. The Company operates in the United States, the UK, Germany and Canada and is incorporated in Delaware, USA.

Your Recent History

Delayed Upgrade Clock